SS

Shital Surykant Shendge

Active Director Additional Director DIN 10151204
DIN 10151204 First appointment May 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Shital Surykant Shendge

Data last updated:

Shital Surykant Shendge is an Additional Director at Casmedz Pharma Private Limited (since 2023). The company operates in Paper.

DIN 10151204
Primary Designation Additional Director
Industry Paper
First Appointment 10 May 2023
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Casmedz Pharma Private Limited U21001MH2021PTC369184
Additional Director10 May 20232021Active

Board colleagues of Shital Surykant Shendge

Directorship timeline

Open interactive timeline →
Casmedz Pharma Private Limited
Premium access

Shareholding and investment profile for Shital Surykant Shendge

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shital Surykant Shendge

Shital Surykant Shendge currently holds 1 directorship: Casmedz Pharma Private Limited (Additional Director, since 10 May 2023).

Shital Surykant Shendge was first appointed on 10 May 2023 as Additional Director at Casmedz Pharma Private Limited.

The current boards of Shital Surykant Shendge's companies include Pallavi Anil Zende (Casmedz Pharma Private Limited), Supriya Chandrakant Shivpuje (Casmedz Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available